Selenium nanoparticles coated with pH responsive silk fibroin complex for fingolimod release and enhanced targeting in thyroid cancer-Reference-Cited by-同舟云学术

Selenium nanoparticles coated with pH responsive silk fibroin complex for fingolimod release and enhanced targeting in thyroid cancer

Published:2021-01-01 Issue:1 Volume:49 Page:83-95
ISSN:2169-1401
Container-title:Artificial Cells, Nanomedicine, and Biotechnology
language:en
Short-container-title:Artificial Cells, Nanomedicine, and Biotechnology

Author:

Zou Xiangcai¹²,Jiang Zhipeng³,Li Liang⁴,Huang Zonghai¹

Affiliation:

1. Department of General Surgery, Zhujiang Hospital, Southern Medical University/The Second School of Clinical Medicine, Southern Medical University, Guangzhou, China

2. Department of General Surgery, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China

3. Department of Gastrointestinal Surgery, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, China

4. Digestive Medicine Center, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, China

Funder

New Technology Project of the Second Affiliated Hospital of Guangzhou Medical University

Publisher

Informa UK Limited

Subject

Pharmaceutical Science,Biomedical Engineering,General Medicine,Medicine (miscellaneous),Biotechnology

Link

https://www.tandfonline.com/doi/pdf/10.1080/21691401.2021.1871620

Reference48 articles.

1. Consensus Statement on the Terminology and Classification of Central Neck Dissection for Thyroid Cancer

2. The Impact of Diagnostic Changes on the Rise in Thyroid Cancer Incidence: A Population-Based Study in Selected High-Resource Countries

3. Thyroid cancer

4. Progress in molecular-based management of differentiated thyroid cancer

5. Prognostic value of the eighth edition AJCC TNM classification for differentiated thyroid carcinoma

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. pH responsive fabrication of PVA-stabilized selenium nano formulation encapsulated with luteolin to reduce diabetic ureteral injury by decreasing NLRP3 inflammasome via Nrf2/ARE signaling;Regenerative Therapy;2024-12

2. Surface engineered multifunctional nano-systems for localised drug delivery against thyroid cancer: A review of current practices;Biomedicine & Pharmacotherapy;2024-07

3. Research and therapeutic applications of silk proteins in cancer;Journal of Biomaterials Applications;2023-06-21

4. Advances in Antioxidant Applications for Combating 131I Side Effects in Thyroid Cancer Treatment;Toxics;2023-06-13

5. Selenium and thyroid diseases;Frontiers in Endocrinology;2023-03-24